© 2025 Columbia Data Analytics, LLC. All rights reserved. Terms, Conditions, and Privacy
Our team of economists, biostatisticians, epidemiologists and medical writers collaborate to build compelling content for different readers and audiences.
We maintain productive relationships with universities and medical institutions to create a team of Key Opinion Leaders (KOLs) and faculty to consult and advise on publications.
The CDA team has an impressive peer-reviewed publication record, with international expertise in a wide variety of therapeutic areas. We have published more than 500 articles in high-quality journals such as JAMA, Medical Care, Health Policy, Current Medical Research & Opinion, Journal of Medical Economics, and Value in Health. Our team members frequently review peer-reviewed journal articles and supply publication support.
Publication / Presentation Year | Therapeutic Area | Journal / Conference | Title |
|---|---|---|---|
2025 | Mental Health / Neurology | AMCP Annual | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness |
2025 | Virology; Women's Health | American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting | Evaluating the relationship between Medicaid postpartum depression (PPD) screening and coverage policies on PPD diagnosis incidence in the United States |
2025 | Mental Health / Neurology | AMCP Annual | Real-world treatment patterns, healthcare resource utilization and costs for Medicaid patients with a postpartum depression diagnosis |
2025 | Obesity / Endocrinology | Tirzepatide and semaglutide for the treatment of obstructive sleep apnea and obesity: A retrospective analysis | |
2024 | Oncology | Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide | |
2024 | Obesity / Endocrinology | The association between weight loss medications and cardiovascular complications | |
2024 | Obesity / Endocrinology | The impact of newly approved anti-obesity medications on osteoarthritis | |
2024 | Obesity / Endocrinology | Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | Semaglutide and tirzepatide use and reduction of cardiovascular risks in adults with overweight and obesity | |
2024 | Mental Health / Neurology | Neighborhood socioeconomic status and postpartum depression among commercial health insurance enrollees: A retrospective cohort study | |
2024 | Hepatology; Methodology | Artificial intelligence in identifying patients with undiagnosed nonalcoholic steatohepatitis | |
2024 | Mental Health / Neurology | Behind the sadness of teen girls: A retrospective survey analysis | |
2024 | Mental Health / Neurology | Mental health disparities in young adults with arrest history: A survey-based, cross-sectional analysis | |
2023 | Dataset Comparison | Use of open claims vs closed claims in health outcomes research | |
2023 | Virology | Short-term and long-term behavioral effects of vaccination mandates | |
2023 | Mental Health / Neurology | Factors associated with the prevalence and treatment of depression in adolescent males in the US during the period of COVID-19 pandemic | |
2023 | Obesity / Endocrinology | Relationship between body mass index and diagnosis of overweight or obesity in Veterans Administration population | |
2024 | Mental Health / Neurology | Psych Congress | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness |
2019 | Mental Health / Neurology | Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis | |
2024 | Obesity / Endocrinology; Mental Health / Neurology | Comparative effect of Ozempic, Wegovy and Mounjaro on the incidence of alcohol and substance use disorder in patients with obesity | |
2024 | Mental Health / Neurology | Socioeconomic status and postpartum depression among commercial health insurance enrollees | |
2024 | Mental Health / Neurology | AMCP Annual Meeting | Open access for mental health medication: Impact on state Medicaid budgets |
2023 | Mental Health / Neurology | ISPOR EU | Mental health disparities for young adults with arrest history: A survey-based, cross-sectional analysis |
2024 | Obesity / Endocrinology | A retrospective analysis of the impact of approved anti-obesity medications on the risk of cardiovascular disease in patients with obesity | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of cardiovascular disease, healthcare resource use and costs among patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of osteoarthritis, healthcare resource use and costs among patients with obesity: A retrospective cohort study BEST RESEARCH POSTER AWARD | |
2024 | Obesity / Endocrinology | Anti-obesity medications and related osteoarthritis risk among patients with obesity | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the risk of obstructive sleep apnea in patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of obstructive sleep apnea, healthcare resource utilization and costs among patients with obesity: A retrospective cohort study FINALIST AWARD | |
2024 | Obesity / Endocrinology | Measuring the cardiovascular benefits of anti-obesity medications | |
2024 | Obesity / Endocrinology | Head-to-head comparison of healthcare costs and utilization among patients with semaglutide vs tirzepatide use | |
2024 | Obesity / Endocrinology | Likelihood of osteoarthritis among users of anti-obesity medications | |
2024 | Obesity / Endocrinology | Likelihood of obstructive sleep apnea among patients with obesity and anti-obesity medication use | |
2024 | Obesity / Endocrinology | Effect of anti-obesity medications on cardiovascular events in the Veterans Affairs patient population | |
2024 | Obesity / Endocrinology | Effect of weight loss medications on cardiovascular risk among active US military personnel BRONZE RIBBON AWARD | |
2024 | Obesity / Endocrinology | Cardiovascular benefits of weight loss medications: An analysis of Mounjaro and Wegovy in the US Medicare population | |
2024 | Virology | American Public Health Association (APHA) Annual Meeting & Expo | The association between socioeconomic status and the likelihood and severity of RSV-attributable lower respiratory infections in infants |
2024 | Virology | Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting | The association between socioeconomic status and maternal risk factors on the likelihood and severity of RSV-attributable lower respiratory infections from MarketScan data |
2024 | Oncology | The cardiovascular effect of abiraterone and enzalutamide among Veterans Affairs’ metastatic castration-resistant prostate cancer patients PODIUM PRESENTATION | |
2024 | Obesity / Endocrinology | The effect of newly approved obesity medications on cardiovascular complications | |
2024 | Obesity / Endocrinology; Mental Health | The effect of approved anti-obesity medications in patients with alcohol and substance use disorder | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on osteoarthritis risk in patients with obesity: A retrospective cohort study | |
2024 | Hepatology; Methodology | Predictive risk score for nonalcoholic steatohepatitis among patients in the Department of Defense population | |
2024 | Mental Health / Neurology | Psych Congress | The effect of Medicaid reimbursement policies on serious mental illness outcomes |
2024 | Mental Health / Neurology | Psych Congress | The effect of the Medicaid institutions for mental disease exception on serious mental illness outcomes |
2024 | Obesity / Endocrinology | Impact of Ozempic vs Wegovy on osteoarthritis risk in obese patients: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The effect of approved obesity medications on obesity’s cardiovascular related comorbidities | |
2023 | Oncology | AMCP Nexus | Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide in Veteran Affairs |
2023 | Virology; Vaccine | ISPOR EU | The short-run and long-run behavioral effects of vaccination enforcement in Turkey |
2023 | Immunology | ISPOR EU | Direct medical costs associated with rheumatoid arthritis in Turkey: Analysis from a national claims database |
2023 | Oncology | ISPOR Annual | Effect of surgical choices on the cost of breast cancer care |
2023 | Obesity / Endocrinology | ISPOR Annual | Relationship between body mass index and diagnosis of overweight or obesity in Veteran’s Administration population |
2023 | Hepatology; Methodology | ISPOR Annual | Applying machine learning techniques to identify undiagnosed patients with nonalcoholic steatohepatitis |
2023 | Virology; Vaccine | ISPOR Annual | The short run and long run behavioral effects of COVID-19 vaccination enforcement |
2023 | Immunology | ISPOR Annual | Analysis of rare events in outcomes research using Department of Defense data: Intravenous immune globulin therapy for bullous pemphigoid |
2023 | Database Comparison | ISPOR Annual | Use of open claims vs closed claims on health outcomes research |
2023 | Methodology | ISPOR Annual | Review of machine learning based disease diagnosis modeling |
2023 | Cardiovascular | Geographic variation in clinical outcomes and anticoagulation among Medicare beneficiaries with non-valvular atrial fibrillation | |
2023 | Cardiovascular | Temporal trends in anticoagulation use and clinical outcomes among Medicare beneficiaries with non-valvular atrial fibrillation | |
2023 | Cardiovascular | Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States | |
2023 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin in patients with venous thromboembolism with risk factors for bleeding or for recurrences | |
2023 | Cardiovascular | Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study | |
2023 | Cardiovascular | Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and multimorbidity | |
2022 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding | |
2022 | Cardiovascular | Risk levels and adverse clinical outcomes among patients with nonvalvular atrial fibrillation receiving oral anticoagulants | |
2023 | Cardiovascular | Oral anticoagulant underutilization among elderly patients with atrial fibrillation: Insights from the United States Medicare database | |
2022 | Cardiovascular | Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: A retrospective analysis of administrative claims databases | |
2022 | Cardiovascular | Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database | |
2022 | Cardiovascular | Non-persistence to oral anticoagulation treatment in non-valvular atrial fibrillation patients in the United States | |
2021 | Virology; Vaccine; Public Health | Population density index and its use for distribution of Covid-19: A case study using Turkish data | |
2021 | Immunology | Prevalence of mastocytosis and Hymenoptera venom allergy in the United States | |
2021 | Cardiovascular; Oncology | Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients with active cancer | |
2021 | Cardiovascular | Effectiveness and safety of apixaban versus warfarin among older patients with venous thromboembolism with different demographics and socioeconomic status | |
2021 | Cardiovascular | Non-persistence to oral anticoagulation treatment in non-valvular atrial fibrillation patients in the United States | |
2021 | Cardiovascular | Oral anticoagulants for nonvalvular atrial fibrillation in patients with high risk of gastrointestinal bleeding | |
2021 | Cardiovascular | Use of non-vitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and multimorbidity | |
2021 | Cardiovascular | Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients | |
2021 | Cardiovascular | Clinical and economic outcomes among non-valvular atrial fibrillation patients with coronary artery disease and/or peripheral artery disease | |
2021 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin in venous thromboembolism patients with obesity and morbid obesity | |
2021 | Cardiovascular | Oral anticoagulants for non-valvular atrial fibrillation in frail elderly patients: Insights from the ARISTOPHANES study | |
2021 | Cardiovascular | Safety and effectiveness of apixaban compared with warfarin among clinically relevant subgroups of venous thromboembolism patients in the United States Medicare population | |
2021 | Cardiovascular | Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy | |
2020 | Virology; Infectious Disease | Real-world adherence and persistence for newly-prescribed HIV treatment: Single versus multiple tablet regimen comparison among US Medicaid beneficiaries | |
2020 | Oncology | Economic outcomes in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate plus prednisone | |
2020 | Oncology; Rare Diseases | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data | |
2020 | Cardiovascular; Pulmonary | Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: A retrospective database analysis | |
2020 | Cardiovascular | Effectiveness and safety of oral anticoagulants among NVAF patients with obesity: Insights from the ARISTOPHANES Study | |
2020 | Cardiovascular | Effectiveness and safety of oral anticoagulants in patients with nonvalvular atrial fibrillation and diabetes mellitus | |
2020 | Hematology; Rare Diseases; Hereditary Diseases | Medical resource use and costs of treating sickle cell-related vaso-occlusive crisis episodes: A retrospective claims study | |
2020 | Oncology; Rare Diseases | Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis | |
2020 | Infectious Disease; Virology | Predictors and outcomes of hospitalization for influenza: Real-world evidence from the United States Medicare population | |
2020 | Respiratory; Virology | A real-world analysis of patient characteristics and predictors of hospitalization among US Medicare beneficiaries with respiratory syncytial virus infection | |
2020 | Mental Health | An evaluation of the clinical and economic burden among older adult Medicare-covered beneficiaries with treatment-resistant depression | |
2019 | Hematology; Rare Disease; Hereditary Disease | Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study | |
2019 | Cardiovascular | Healthcare resource utilization and expenditures among newly diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants | |
2019 | Cardiovascular | Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population | |
2019 | Cardiovascular | Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients | |
2019 | Cardiovascular | Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population | |
2019 | Cardiovascular | Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure | |
2019 | Cardiovascular | Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: A retrospective cohort study | |
2019 | Cardiovascular | Risk of venous thromboembolism after new onset heart failure | |
2019 | Cardiovascular | The value of sPESI for risk stratification in patients with pulmonary embolism | |
2019 | Oncology | ISPOR Annual | Real-world evidence of the economic burden and risk factors for hospitalization among patients with myeloma in the US Veterans Health Administration population |
2019 | Cardiovascular Diseases | ISPOR Annual | Assessing the risk factors of heart failure among patients in the US Department of Defense population |
2019 | Hepatology | ISPOR Annual | Assessing the economic burden and hospitalization among patients with non-alcoholic steatohepatitis in the US Veterans Health Administration population |
2019 | Respiratory | ISPOR Annual | Examining the risk factors of chronic obstructive pulmonary disease among patients in the Department of Defense population |
2019 | Immunology | ISPOR Annual | Assessing the economic burden and predictors of hospitalization among US veteran patients with rheumatoid arthritis: A retrospective case-control study |
2019 | Oncology | Annual Meeting of the American Urological Association (AUA) Education and Research Inc | Survival rates and economic outcomes in chemotherapy-naïve metastatic castrate resistant prostate cancer patients treated with abiraterone acetate or enzalutamide |
2019 | Oncology | Annual Meeting of the American Urological Association (AUA) Education and Research Inc. | Impact of prostate specific antigen doubling time on metastasis and increased costs associated with progression to metastatic castrate-resistant prostate cancer |
2019 | Respiratory | AMCP Annual | Assessing economic burden and hospitalization among asthma patients in the US Veterans Health Administration population |
2019 | Oncology; Rare Disease | European School of Haematology: How to Diagnose and Treat CML/MPN | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data |
2019 | Oncology | American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium | Impact of prostate specific antigen doubling time on time to metastasis and overall survival in nonmetastatic castration-resistant prostate cancer patients |
2019 | Oncology | American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium | Overall survival by race in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide |
2019 | Public Health | Network among HTA ecosystem | |
2019 | Public Health; Policy | Does the unification of health financing affect the distribution pattern of out‐of‐pocket health expenses in Turkey? | |
2019 | Obesity / Endocrinology | Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1 RAs in type II diabetes patients | |
2019 | Cardiovascular Diseases | Predictors of hospital length of stay among patients with low-risk pulmonary embolism | |
2019 | Respiratory | The burden of hypoxic respiratory failure in preterm and term/near-term infants in the United States 2011-2015 | |
2019 | Mental Health | Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis | |
2019 | Oncology; surgery | Impact of surgical approach on short-term oncological outcomes and recovery following low anterior resection for rectal cancer | |
2019 | Oncology; surgery | The effect of the breast cancer provider discussion law on breast reconstruction rates in New York state | |
2019 | Oncology; Hematology; Rare disease | Hematocrit levels and thrombotic events in patients with polycythemia vera: An analysis of Veterans Health Administration data | |
2019 | Respiratory | Reduction in hospital readmission rates among Medicare beneficiaries with chronic obstructive pulmonary disease: A real-world outcomes study of nebulized bronchodilators | |
2019 | Hematology; Hereditary Diseases; Rare Diseases | Sickle cell disease complications: Prevalence and resource utilization | |
2019 | Hematology; Hereditary Diseases; Rare Diseases | Evaluation of vaso-occlusive crises in United States sickle cell disease patients: A retrospective claims-based study | |
2018 | Cardiovascular Diseases | Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients: The ARISTOPHANES Study | |
2018 | Cardiovascular Diseases | Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and concomitant coronary/peripheral artery disease | |
2018 | Cardiovascular Diseases | J Manag Care Specialty Pharm | Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in non-valvular atrial fibrillation patients in the United States Department of Defense population |
2018 | Cardiovascular Diseases | J Manag Care Pharm | A real-world observational study of hospitalization and health care costs among non-valvular atrial fibrillation patients prescribed oral anticoagulants in the United States Medicare population |
2018 | Cardiovascular Diseases | Heart Asia | East meets West: The influence of racial, ethnic and cultural risk factors on cardiac surgical risk model performance |
2018 | Cardiovascular Diseases | Ann Pharmacother | Effect of renal function on dosing of non-vitamin K-antagonist direct oral anticoagulants among patients with non-valvular atrial fibrillation |
2018 | Immunology; Rheumatology | Rheum Adv Pract | Burden of rheumatoid arthritis in the US elderly population: Comorbidities, healthcare resource utilization, and costs |
2018 | Women's Health | Contraception | Long-term outcomes after elective sterilization procedures—A comparative retrospective cohort study of Medicaid patients |
CDA houses the Journal of Health Economics and Outcomes Research, an online journal with an external academic editorial board from top-level universities, with published papers from numerous well-known professors, scientists, universities, companies, and institutions and is currently indexed in PubMed, PubMed Central (PMC), DOAJ, and Google Scholar.
JHEOR operates independently of CDA’s client-based publication services. To learn more about JHEOR and read published articles, follow the link below.
145 Hudson Street
Suite 205
New York, NY 10013
(332) 219-9977
info@cdanyc.com
© 2025 Columbia Data Analytics, LLC. All rights reserved. Terms, Conditions, and Privacy